DOI: 10.2337/diacare.29.02.06.dc05-1830 © 2006 by the American Diabetes Association
The Effectiveness of ß-Blockers After Myocardial Infarction in Patients With Type 2 DiabetesResponse to McDonald et al.University of Alabama at Birmingham, Birmingham, Alabama Address correspondence to David S. H. Bell, MB, FACE, Faculty Office Tower, Room 754, 510 South 20th St., Birmingham, AL 35294. E-mail: dshbell@uab.edu
In the September 2005 issue of Diabetes Care, McDonald et al. (1) showed that ß-blocker therapy after myocardial infarction (MI) was not associated with reduced mortality or fewer recurrent events in people with type 2 diabetes in routine practice. This contrasted with studies performed before intervention with
|
| |||||||||||||||||||||||||||